Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ELELYSO safely and effectively. See full prescribing information for ELELYSO. ELELYSO® (taliglucerase alfa) for injection, for intravenous use Initial U.S. Approval: 2012
Medication labelWhy this: Advisory · dailymed-prescription
ELELYSO is indicated for the treatment of patients 4 years of age and older with a confirmed diagnosis of Type 1 Gaucher disease.
- generic_name
- taliglucerase alfa
- product_names
- Taliglucerase alfa
- ndc
- 0069-0106, 0069-0106-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en